Molecular and genetic aspects of resistance to azoles in Candida albicans;Aspectos moleculares y genéticos de la resistencia a azoles en Candida albicans

Revista Iberoamericana de Micologia

Volumn 14, Issue 4, 1997, Pages 150-154

  Hernáez, María Luisa ^a   Pla, Jesús ^a   Nombela, César ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Azoles; Candida albicans; Fluconazole; Resistance; Transporters

Indexed keywords

ARTICLE;

EID: 0001766407     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Fox JL. Fungal infection rates are increasing. ASM News 1993; 10 515-518.
2. Shaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection Am J Med 1991;91(Suppl 3B). 723-53.
3. Vaque Rafart J, Baquero Mochales F, Monge Jodra V, et al. Proyecto EPINE 1992 Barcelona, Grafimed Publ., 1993.
4. Bennett JE. Antimicrobial agents: antifungal agents. In Gilman AG, Rall TW, Sies AS, Taylor P (Eds.) Goodman and Gilman's the pharmacological basis of therapeutics. Elmsford. Pergamon Press, 1996: 1165-1181.
5. Madrenys i Brunet N, Torres-Rodríguez JM. Anfotericina B complejo lipídico (ABLC): Nueva formulación de un antifúngico clásico. Rev Iberoam Micol 1996; 13 (Supl 2): S95-S100.
6. Yeagle PL, Martin RB, Lala AK, Block K. Differential effects of cholesterol and lanosterol on artificial membranes. Proc Natl Acad Sci USA 1977: 74, 4924-4926
7. Ng TT, Denning DW. Fluconazole resistance in Candida in patients with AIDS-a therapeutic approach. J Infect 1993; 26 117-125.
8. Horsburgh CR, Kirkpatrick CW Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med 1983; 74: 23-29.
9. Warnock DW, Johnson EM, Richardson MD, Vickers CFH. Modified response to ketoconazole of Candida albicans from a treatment failure. Lancet 1983; i: 642-643.
10. Baily GG, Perry FM, Denning DW. Mandal BK Fluconazole-resistant candidosis in an HIV cohort. AIDS 1994; 8: 787-792
11. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 1: 1-8.
12. Odds FC. Resistance of yeasts to azolederivative antifungals. J Antimicrob Chemother 1993; 31 463-471.
13. Vanden Bossche H, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi. Trends Microbiol 1994; 2: 393-400.
14. Hitchcock CA. Resistance of Candida albicans to azole antifungal agents. Biochem Soc Trans 1993, 21: 1039-1047
15. Vanden Bossohe H, Marichal P, Gorrens J, Bellens D, Moereels H, Janssen PA Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals. Biochem Soc Trans 1990: 18: 56-59.
16. Hitchcock CA, Russell NJ, Barrett-Bee KJ Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C albicans 6.4 Crit Rev Microbiol 1987; 15. 111-115.
17. Vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene MC. Charactenzation of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992; 12: 2602-2610.
18. Ryley JF, Wilson RG, Barrett-Bee KJ. Azole resistance in Candida albicans. J Med Vet Mycol 1984, 22: 53-63.
19. Hitchcock CA, Barrett BK, Russell NJ The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans. J Gen Microbiol 1986; 132: 2421-2431
20. Hitchcock CA, Barrett-Bee KJ, Russell NJ. The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans. J Med Vet Mycol 1987; 25: 29-37.
21. Levy SB. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 1992; 4: 695-703.
22. Odds FC. Candida and candidosis (2 Ed). London. Ballière Tindall, 1988.
23. Scherer S, Magee PT. Genetics of Candida albicans. Microbiol Rev 1990; 54: 226-241.
24. Kirsch DR, Kelly R, Kurtz MB. The genetics of Candida. En: Kirsch DR, Kelly R, Kurtz MB (Eds). Boca Raton, CRC Press, 1990.
25. Pla J, Pérez-Diaz RM, Navarro-García F, Sánchez M, Nombela C. Cloning of the Candida albicans HIS1 gene by direct complementation of a C. albicans histidine auxotroph using an improved double-ARS shuttle vector Gene 1995; 165, 115-120.
26. Balzi E, Goffeau A Multiple or pleiotropic drug resistance in yeast. Biochim Biophys Acta 1991; 1073: 241-252.
27. Balzi E, Goffeau A. Genetics and biochemistry of yeast multidrug resistance. Biochim Biophys Acta 1994; 1187: 152-162.
28. Balzi E, Goffeau A. Yeast multidrug resistance, the PDR network. J Bioenerg Biomembr 1995; 27: 71-76.
29. Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA, Koltin Y. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 1991; 227: 318-329.
30. Ben-Yaacov R, Knoller S, Caldwell GA. Becker JM, Koltin Y. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 1994; 4: 648-652.
31. Marger MD, Saier MH. A major superfamily of transmembrane facilitators that catalyse uniport. symport and antiport. Trends Biochem Sci 1993; 18: 13-20.
32. Sasnauskas K, Jomantiene R, Lebediene E, Lebedys J, Januska A, Janulaitis A. Cloning and sequence analysis of a Candida maltosa gene which confers resistance to cycloheximide Gene 1992, 116: 105-108.
33. Jia Z-P, McCullough N, Wong L, Young PG. The amilonde resistance gene, car1. of Schizosaccharomyces pombe Mol Gen Genet 1993; 241: 298-304.
34. Becker JM Henry LK, Jiang W. Koltin Y Reduced virulence of Candida albicans mutants affected in multidrug resistance. Infect Immun 1995; 63: 4515-4518.
35. Goldway M, Teff D, Schmidt R, Oppenheim AB, Koltin Y. Multidrug resistance in Candida albicans disruption of the BENR gene. Antimicrob Agents Chemother 1995; 39:422-426
36. Sanglard D, Ischer F, Monod M, Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 1996: 10: 2300-2305.
37. Prasad R, De Wergifosse P, Goffeau A, Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 1995, 27: 320-329.
38. Balzi E, Wang M, Leterme S, Van Dyck L, Goffeau A. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem 1994, 269: 2206-2214.
39. Servos J, Haase E, Brendel M. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol Gen Genet 1993; 236: 214-218.
40. Leppert G, McDevitt R, Falco SC, Van Dyk TK, Ficke MB, Golin J. Cloning by gene amplification of two loci conferring multiple drug resistance in Saccharomyces. Genetics 1990; 125: 13-20.
41. Higgins DG, Bleasby AJ, Fuchs R, CLUSTAL V. Improved software for multiple sequence alignment. Comput Appl Biosci 1992; 2: 189-191.
42. Higgins CF. The ABC of channel regulation Cell 1995, 82: 693-696.
43. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995; 39: 2378-2386.
44. Sanglard D, Ischer F, Monod M, Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 1997; 143:405-416.
45. Albertson GD, Niimi M, Cannon R, Jenkinson HF. Multiple eflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 1996; 40: 2835-2841.
46. Decottignies A, Kolaczkowski M, Balzi E, Goffeau A. Solubilization and characterization of the overexpressed PDR5 multidrug resistance nucleotide triphosphatase of yeast. J Biol Chem 1994; 269: 12797-12803.
47. Meyers S, Schauer W, Balzi E, Wagner M, Goffeau A, Golin J. Interaction of the yeast pleiotropic drug resistance genes PDR1 and PDR5. Curr Genet 1992; 21: 431-436.